ABIVAX PHASE 3 PROGRAM WITH OBEFAZIMOD IN ULCERATIVE COLITIS PROGRESSES WITH US IRB APPROVAL Written by Kai Schmitz on 4th August 2022. Posted in Client News. Previous Next
